Sarah Jane de Dios
Gerontology · la Mesa, CANPI 1528632742
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 30.3% of the total. Reporting peaked in 2022 at $1,106 and has fallen 85.9% since, to $155 in 2025.
Across 112 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$648
- Teva Pharmaceuticals USA, Inc.$390
- Biogen$309
- Neurocrine Biosciences, Inc.$228
- Novartis$79
- Amgen$62
- plus $423 from 15 others
What the payments were for
- Food & beverage$2,139100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 51 | $648 |
| Teva Pharmaceuticals USA, Inc. | 17 | $390 |
| Biogen | 8 | $309 |
| Neurocrine Biosciences, Inc. | 7 | $228 |
| Novartis | 5 | $79 |
| Amgen | 4 | $62 |
| Acadia Pharmaceuticals Inc | 3 | $54 |
| Kyowa Kirin, Inc. | 2 | $52 |
| Pfizer | 2 | $50 |
| Neurelis, Inc. | 2 | $30 |
| Nevro Corp. | 1 | $29 |
| SK Life Science, Inc. | 1 | $29 |
| Lundbeck LLC | 1 | $29 |
| Banner Life Sciences, LLC | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Adamas Pharmaceuticals, Inc. | 1 | $23 |
| Sanofi | 1 | $21 |
| Lilly USA, LLC | 1 | $16 |
| Grifols USA, LLC | 1 | $15 |
| EMD Serono, Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,139 in reported general payments places this provider in the 85th percentile of 348 gerontology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Emgality PenGalcanezumab-Gnlm | 13 | $8,715 |
| Levetiracetam | 29 | $665 |
| Gabapentin | 47 | $458 |
| Ondansetron OdtOndansetron | 48 | $343 |
| Sumatriptan Succinate | 11 | $246 |
| Oxycodone Hcl | 58 | $211 |
| Amitriptyline Hcl | 11 | $96 |
| Sertraline Hcl | 13 | $88 |
| Famotidine | 17 | $39 |
Paid to pharmacies, not to this prescriber.
Other gerontology in la Mesa
- Lovely IsraelSanta Monica$95K
- Leslie TarlowLos Angeles$58K
- Christine PartamianPorter Ranch$41K
- Elsa Pineda-FloresLos Angeles$24K
- Maria MottaDuarte$23K
- Daniel ChiuOrange$17K
- Katiaryna KulinichChula Vista$15K
- Nataliya OsorioRiverside$13K
- Anne Marie de Joya ReeveDuarte$11K
- Wendy AlmonteLemoore$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.